Decreased bone mineral density in patients with neurofibromatosis 1
- 277 Downloads
Neurofibromatosis 1 (NF1) is one of the most common autosomal dominant diseases. Although there is a considerable variability in clinical expression, NF1 is almost fully penetrant in adult patients and may be associated with a variety of skeletal anomalies. Spinal deformities are the most common skeletal manifestation, with an incidence estimated from 10–25% in various studies. Some NF1 patients have a dystrophic form of scoliosis, which is characterized by early age at onset and rapid progression. Complications have been reported during spinal instrumentation of dystrophic curves due to soft, non-resistant vertebral bony tissue, suggesting that an alteration of bone quality may occur in NF1 patients. Recent studies have suggested that decreased bone mineral density (BMD) may occur among patients with NF1. We performed a cross-sectional study on 104 adults with NF1, using quantitative ultrasonometry (QUS) to investigate whether decreased BMD is a general phenomenon in NF1 patients. The data reveal that BMD, as measured by age- and gender- adjusted Z-scores, is significantly lower in NF1 patients than in the normal reference population. The decrease in BMD appears to be even more marked among NF1 patients with scoliosis that requires surgical treatment. The findings indicate that NF1 produces a generalized alteration of bone in addition to the focal osseous dysplasias of the vertebrae, tibia, and sphenoid wing that characterize this condition. The pathological mechanism underlying these bony changes remains to be elucidated.
KeywordsBone mineral density Neurofibromatosis type 1 Quantitative ultrasonometry Scoliosis
This work is, in part, supported by the German lay foundation for neurofibromatosis: Von-Recklinghausen Gesellschaft.
- 3.DeClue JE, Cohen BD, Lowy DR (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A 88:9914–9918Google Scholar
- 7.Crawford AH (1994) Neurofibromatosis. In: Weinstein SL (ed) The pediatric spine. Raven Press, New York, pp 619–649Google Scholar
- 12.WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843: WHO, GenevaGoogle Scholar
- 16.Kang C, Speller R (1998) Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus. Br J Radiol 71:861–867Google Scholar
- 19.Dachverband Deutschsprachiger Wissenschaftlicher Gesellschaften für Osteologie (DVO) (2002) Postmenopausal OsteoporosisGoogle Scholar
- 20.Huson SM (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson SM, Hughes RAC (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall Medical, London, pp 160–203Google Scholar
- 22.Jakes RW, Khaw K, Day NE, Bingham S, Welch A, Oakes S, Luben R, Dalzell N, Reeve J, Wareham NJ (2001) Patterns of physical activity and ultrasound attenuation by heel bone among Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): population based study. BMJ 322:140PubMedGoogle Scholar
- 25.Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E, Romanus B, Tudisco C, Wientroub S (2000) Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9:11–15Google Scholar
- 26.Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P (2000) Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9:3–10Google Scholar